HighTower Advisors’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-27,431
| Closed | -$4.86M | – | 2583 |
|
|
2020
Q1 | $4.86M | Buy |
27,431
+2,039
| +8% | +$384K | 0.03% | 458 |
|
|
2019
Q4 | $4.85M | Buy |
25,392
+324
| +1% | +$58.4K | 0.03% | 554 |
|
|
2019
Q3 | $4.22M | Sell |
25,068
-77,380
| -76% | -$12.6M | 0.02% | 623 |
|
|
2019
Q2 | $17.2M | Sell |
102,448
-38,345
| -27% | -$5.31M | 0.1% | 213 |
|
|
2019
Q1 | $20.5M | Buy |
140,793
+48,828
| +53% | +$7.08M | 0.14% | 159 |
|
|
2018
Q4 | $12.3M | Sell |
91,965
-40,783
| -31% | -$6.69M | 0.09% | 220 |
|
|
2018
Q3 | $25.3M | Buy |
132,748
+29,075
| +28% | +$5.34M | 0.18% | 109 |
|
|
2018
Q2 | $17.4M | Sell |
103,673
-6,991
| -6% | -$1.12M | 0.14% | 165 |
|
|
2018
Q1 | $18.7M | Buy |
110,664
+47,607
| +75% | +$7.99M | 0.16% | 133 |
|
|
2017
Q4 | $10.3M | Sell |
63,057
-19,508
| -24% | -$3.5M | 0.08% | 259 |
|
|
2017
Q3 | $16.8M | Sell |
82,565
-8,532
| -9% | -$1.98M | 0.14% | 151 |
|
|
2017
Q2 | $22.1M | Buy |
91,097
+21,482
| +31% | +$5.05M | 0.2% | 109 |
|
|
2017
Q1 | $16.6M | Buy |
69,615
+10,090
| +17% | +$2.35M | 0.16% | 128 |
|
|
2016
Q4 | $12.5M | Buy |
59,525
+18,709
| +46% | +$3.88M | 0.14% | 161 |
|
|
2016
Q3 | $9.42M | Buy |
40,816
+6,474
| +19% | +$1.58M | 0.11% | 194 |
|
|
2016
Q2 | $7.94M | Sell |
34,342
-7,096
| -17% | -$1.64M | 0.1% | 221 |
|
|
2016
Q1 | $11.1M | Sell |
41,438
-702
| -2% | -$201K | 0.04% | 178 |
|
|
2015
Q4 | $13.2M | Buy |
42,140
+10,482
| +33% | +$3.12M | 0.16% | 142 |
|
|
2015
Q3 | $8.62M | Buy |
31,658
+8,751
| +38% | +$2.69M | 0.11% | 193 |
|
|
2015
Q2 | $6.99M | Sell |
22,907
-522
| -2% | -$156K | 0.11% | 194 |
|
|
2015
Q1 | $6.98M | Buy |
23,429
+3,185
| +16% | +$908K | 0.1% | 217 |
|
|
2014
Q4 | $5.21M | Buy |
20,244
+729
| +4% | +$182K | 0.08% | 269 |
|
|
2014
Q3 | $4.71M | Sell |
19,515
-7,693
| -28% | -$1.72M | 0.08% | 280 |
|
|
2014
Q2 | $6.07M | Buy |
27,208
+14,094
| +107% | +$2.92M | 0.11% | 212 |
|
|
2014
Q1 | $2.7M | Sell |
13,114
-2,592
| -17% | -$513K | 0.05% | 416 |
|
|
2013
Q4 | $2.64M | Buy |
15,706
+240
| +2% | +$37.5K | 0.05% | 379 |
|
|
2013
Q3 | $2.23M | Sell |
15,466
-813
| -5% | -$108K | 0.06% | 389 |
|
|
2013
Q2 | $2.06M | Buy |
+16,279
| New | +$1.84M | 0.06% | 388 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
HighTower Advisors's AGN Position: Q2 2020 in Review
HighTower Advisors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 27,431 shares — an estimated $4.86M sold.
HighTower Advisors first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $25.3M in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- HighTower Advisors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- HighTower Advisors sold 27,431 Allergan plc shares in Q2 2020, an estimated $4.86M.
- HighTower Advisors first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- HighTower Advisors's Allergan plc position peaked at $25.3M in Q3 2018.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on HighTower Advisors's 13F filing for Q2 2020, filed 10 Aug 2020.